Retraction
Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia
Paper Information
Record ID:
44991
Author(s):
Journal:
Publication Date:
April 03, 2012
Retraction Date:
June 02, 2023
(2.5 years years ago)
Subjects:
Institutions:
- Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, University of Messina, Messina, Italy
- Department of Biochemical, Physiological and Nutritional Sciences, Section of Physiology and Human Nutrition, University of Messina, Messina, Italy
- Department of Urology, University of Messina, Messina, Italy
- Department of Medical Affairs, Primus Pharmaceuticals Inc., Scottsdale, Arizona, USA
Countries:
Article Type:
Publisher:
Wiley
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (69)
69
Total Citations5
Post-Retraction(7.2%)
64
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
579
Days since retraction (latest)
DuCLOX-2/5 inhibition: a promising target for cancer chemoprevention
Swetlana Gautam, Subhadeep Roy, Mohd Nazam Ansari et al. (6 authors)
Breast Cancer
Published: Aug 2016
31 citations
31 citations
2473 days before retraction
Co-administration of 3-Acetyl-11-Keto-Beta-Boswellic Acid Potentiates the Protective Effect of Celecoxib in Lipopolysaccharide-Induced Cognitive Impairment in Mice: Possible Implication of Anti-inflammatory and Antiglutamatergic Pathways
Aya Shoukry Sayed, Nesrine S. El Sayed
Journal of Molecular Neuroscience
Published: Mar 2016
37 citations
37 citations
2634 days before retraction
Reactive oxygen species: players in the cardiovascular effects of testosterone
Rita C. Tostes, Fernando S. Carneiro, Maria Helena Catelli de Carvalho et al. (4 authors)
AJP Regulatory Integrative and Comparative Physiology
Open Access
Published: Nov 2015
78 citations
78 citations
2766 days before retraction
Retracted: Research Article Flavocoxid Protects Against Cadmium-Induced Disruption of the Blood-Testis Barrier and Improves Testicular Damage and Germ Cell Impairment in Mice
Letteria Minutoli, Antonio Micali, Antonina Pisani et al. (19 authors)
Toxicological Sciences
Open Access
Published: Sep 2015
51 citations
51 citations
2802 days before retraction
Flavocoxid attenuates gentamicin-induced nephrotoxicity in rats
Dalia H. El‐Kashef, Asmaa El-Kenawi, Ghada M. Suddеk et al. (4 authors)
Naunyn-Schmiedeberg s Archives of Pharmacology
Published: Aug 2015
27 citations
27 citations
2849 days before retraction
Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats
Ekaterina A. Lesovaya, Kirill Kirsanov, Elena Antoshina et al. (11 authors)
Oncotarget
Open Access
Published: Apr 2015
29 citations
29 citations
2959 days before retraction
A Dual Inhibitor of Cyclooxygenase and 5-Lipoxygenase Protects Against Kainic Acid-Induced Brain Injury
Letteria Minutoli, Herbert Marini, Mariagrazia Rinaldi et al. (14 authors)
NeuroMolecular Medicine
Published: Apr 2015
31 citations
31 citations
2967 days before retraction
Effects of Resveratrol on Benign Prostatic Hyperplasia by the Regulation of Inflammatory and Apoptotic Proteins
Kyung‐Sook Chung, Se-Yun Cheon, Hyo‐Jin An
Journal of Natural Products
Published: Feb 2015
22 citations
22 citations
3019 days before retraction
Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB
Reem T. Atawia, Hala H. Mosli, Mariane G. Tadros et al. (6 authors)
Naunyn-Schmiedeberg s Archives of Pharmacology
Published: Aug 2014
30 citations
30 citations
3201 days before retraction
Flavocoxid, a Nutraceutical Approach to Blunt Inflammatory Conditions
Alessandra Bitto, Francesco Squadrito, Natasha Irrera et al. (8 authors)
Mediators of Inflammation
Open Access
Published: Jan 2014
47 citations
47 citations
3439 days before retraction
Nonsteroidal Anti-Inflammatory Drugs and Prostatic Diseases
Hitoshi Ishiguro, Takashi Kawahara
BioMed Research International
Open Access
Published: Jan 2014
40 citations
40 citations
3439 days before retraction
Lower Urinary Tract Symptom Improvement After Radical Prostatectomy Correlates With Degree of Prostatic Inflammation
Michael B. Burris, Helen P. Cathro, Casey G. Kowalik et al. (7 authors)
Urology
Published: Nov 2013
7 citations
7 citations
3486 days before retraction
[Urological comorbidities in patients with rheumatoid arthritis : literature review].
Andrée Friedl, Monika Mustak, W. Höltl et al. (4 authors)
PubMed
Published: Nov 2013
2 citations
2 citations
3500 days before retraction
Urologische Begleiterkrankungen bei Patienten mit rheumatoider Arthritis
Andrée Friedl, Monika Mustak, W. Höltl et al. (4 authors)
Zeitschrift für Rheumatologie
Published: Aug 2013
3 citations
3 citations
3584 days before retraction
Future Direction in Pharmacotherapy for Non-neurogenic Male Lower Urinary Tract Symptoms
Roberto Soler, Karl‐Erik Andersson, Michael B. Chancellor et al. (9 authors)
European Urology
Published: May 2013
63 citations
63 citations
3678 days before retraction
The Role of Inflammation in the Progression of Benign Prostatic Hyperplasia
Cosimo De Nunzio, Simone Albisinni, Mauro Gacci et al. (4 authors)
Current Bladder Dysfunction Reports
Published: Apr 2013
15 citations
15 citations
3714 days before retraction
Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist
Ferenc G. Rick, Andrew Abi‐Chaker, Luca Szalontay et al. (13 authors)
Proceedings of the National Academy of Sciences
Open Access
Published: Jan 2013
33 citations
33 citations
3777 days before retraction
Paper citing Effects of flavocoxid, a dual inhibitor of COX and...
Unknown Authors
Unknown Journal
Published: Jan 2013
3777 days before retraction
Flavocoxid (Limbrel ®) manages osteoarthritis through modification of multiple inflammatory pathways: a review
Bruce Burnett, Robert M. Levy
Functional Foods in Health and Disease
Open Access
Published: Nov 2012
7 citations
7 citations
3863 days before retraction
Quick Stats
Total Citations:
69
Years Since Retraction:
2.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025